The Supreme Court has ruled that Novo Nordisk’s description of the patent for Prandin, its diabetes drug, is too broad. This decision enables generic drug manufacturer Caraco Pharmaceuticals to sue the innovator company in an effort to force Novo Nordisk to narrow its patent description.
Walgreen Co. today named former Pfizer Inc. executive Robyn Peters as group vice president of managed market sales. She replaces chief client officer Joseph Terrion, who is leaving the company to pursue personal interests.
CVS Caremark Corp. has named Mark Cosby, a department store executive, to head its retail pharmacy business, effective October 1.
An advisory committee to the Food and Drug Administration has recommended that GlaxoSmithKline PLC’s (GSK) diabetes drug Avandia should remain on the market, but possibly with tough new restrictions and new warnings.
Pharmaprix stores will make their debit card readers more accessible to disabled customers, under an agreement with the Quebec Human Rights Commission. Pharmaprix, operated by Toronto-based Shoppers Drug Mart Corp.
Dietary supplements supplier NBTY Inc. has agreed to be purchased by private equity firm Carlyle Group for $3.8 billion in one of the biggest private equity deals thus far in 2010. Carlyle’s $55 a share cash offer is 47% above NBTY’s stock close on Wednesday. NBTY announced the deal a day after
Former CVS Caremark Corp. chairman Mac Crawford and Wilbur Ross Jr. of WL Ross & Co. are forming a joint venture to invest in and restructure health care companies. The partnership could spend more than $1 billion to "build a major position in health care," Ross said.
Retail sales slipped in June for the second consecutive month, fueling fears that the economy’s turnaround will lose steam over the remainder of the year. Sales dipped 0.5% in June, the Commerce Department reported today. The decline came on the heels of a 1.1% drop in May.
Pharmaceutical industry veteran Dick Domann has been named vice president of sales and business development for the Kerr Health unit of Kerr Drug. "Dick’s immense pharmaceutical background makes him a wonderful addition to our team,” said Kerr chief executive officer Tony Civello.
Pharmaceutical Research and Manufacturers of America (PhRMA) has named John Castellani its new president and chief executive officer, effective September 1.
Merck & Co. is planning to phase out operations at eight research sites and eight manufacturing sites. It is also continuing to consolidate office facilities worldwide as part of the global merger restructuring program that began last December following its acquisition of Schering-Plough Corp.
The provincial government will cut generic drug prices by reducing rebates manufacturers pay to pharmacies, including British Columbia-based London Drugs and Pharmasave.
Community pharmacies in Ontario construed somewhat positively the announcement on May 17 by Deb Matthews, the provincial Minister of Health and Long-Term Care, that she intended to postpone the introduction of new regulations governing pharmacy remuneration for about a month.
How will community pharmacy fare under the new plans for remuneration to be published in final form soon by the Ontario Ministry of Health and Long-Term Care? That theme dominated both formal and informal discussions among delegates to the annual conference of the Canadian Association of Chain Drug
A successful pilot program has set the stage for CVS Caremark Corp.’s rollout of its Consumer Engagement Engine, which provides real-time clinical messaging to pharmacists.
Pharmacists are the most trusted source for medical research information, followed by patient groups and the federal government, according to a recent survey on a variety of health care issues. The poll of 1,000 adults in the United States, commissioned by Research!America and Eli Lilly and Co.
